Bentham Science Logo

Track Your Manuscript:

Current Neuropharmacology

Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access


Current Neuropharmacology, Volume 12 - Number 5

Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks

, 12(5): 387 - 398

Maximilian Gahr

DOI: 10.2174/1570159X12999140619122914

Combination of Therapeutic Hypothermia and Other Neuroprotective Strategies after An Ischemic Cerebral Insult

, 12(5): 399 - 412

Joline Goossens and Said Hachimi-Idrissi

DOI: 10.2174/1570159X12666140424233036

Relevance of Excitable Media Theory and Retinal Spreading Depression Experiments in Preclinical Pharmacological Research

, 12(5): 413 - 433

V.M. Fernandes de Lima and W. Hanke

DOI: 10.2174/1570159X12666140630190800

The Gastrin-Releasing Peptide Receptor (GRPR) in the Spinal Cord as a Novel Pharmacological Target

, 12(5): 434 - 443

Keiko Takanami and Hirotaka Sakamoto

DOI: 10.2174/1570159X12666140923201432

The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review

, 12(5): 444 - 461

Gianluca Serafini, Robert H. Howland, Fabiana Rovedi, Paolo Girardi and Mario Amore

DOI: 10.2174/1570159X12666140619204251

The Endocannabinoid/Endovanilloid System and Depression

, 12(5): 462 - 474

Irena Smaga, Beata Bystrowska, Dawid Gawlinski, Edmund Przegalinski and Malgorzata Filip

DOI: 10.2174/1570159X12666140923205412


Ferdinando Nicoletti
Department of Pharmaceutical Sciences
University Rome"da Sapienza"
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
New eBook

Neurobiology of Mood Disorders

You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog